BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Covance Inc. 

210 Carnegie Center

Princeton  New Jersey  08540-6233  U.S.A.
Phone: 888-COVANCE Fax: 609-452-9375


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.3 billion, global operations in more than 20 countries, and more than 8,100 employees worldwide.

Driven by a commitment to scientific, operational and service excellence, we help sponsors accomplish all of their drug development goals, including:

  • Proving early safety
  • Conducting first-in-human studies
  • Conducting proof-of-concept studies
  • Proving safety and efficacy
  • Filing for marketing approval
  • Launching and marketing a drug
  • Ensuring patient safety and access
  • Managing risk

    We focus on meeting sponsors' timelines, delivering high-quality error-free data and providing exceptional customer service to successfully advance their compounds through the drug development continuum - as safely, efficiently and cost-effectively as possible.

    MAJOR SERVICES AND MARKETS SERVED:
    Worldwide, Covance provides the following drug development services to pharmaceutical and biotechnology companies of all sizes:

  • Research Products
  • Antibody Services
  • Biomarker Services
  • Nonclinical Development Services
  • Clinical Pharmacology Services
  • Cardiac Safety Services
  • Central Laboratory Services
  • Virtual Central Laboratory Services
  • Clinical Development Services
  • Risk Management Services
  • Commercialization Services
  • Outcomes & Consulting Services

    Locations:
    Indianapolis – 8211 SciCor Dr / Indianapolis, IN 46214
    Greenfield - 671 South Meridian Rd/ Greenfield, IN 46140
    Madison - 3301 Kinsman Blvd./Madison, WI 53704


     Key Statistics


    Email: info@covance.com
    Ownership: Public

    Web Site: Covance Inc.
    Employees: 8,100
    Symbol: CVD
     



  • Industry
    Services






     Company News
    Covance Inc. (CVD) And Sihuan Pharmaceutical Initiate Partnership In Preclinical And Clinical Portfolio Development 4/1/2015 8:54:24 AM
    Covance Inc. (CVD) to Hire 120 for New Space 2/25/2015 7:31:30 AM
    Laboratory Corporation of America Holdings (LabCorp) (LH) Completes Acquisition Of Covance Inc. (CVD) 2/19/2015 1:29:21 PM
    Covance Inc. (CVD) Stockholders Approve Acquisition By Laboratory Corporation of America Holdings (LabCorp) (LH) 2/18/2015 7:45:47 AM
    Covance Inc. (CVD) Reports Fourth Quarter Net Revenue Of $634 Million, Pro Forma EPS Of $0.97 And Record Adjusted Net Orders Of $823 Million 2/4/2015 8:47:18 AM
    Covance Inc. (CVD) Launches New Solution To Bridge Preclinical To Clinical Development 1/20/2015 10:27:32 AM
    Covance Inc. (CVD) Sets February 18, 2015 As Date of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Labcorp 1/12/2015 9:34:53 AM
    Covance Inc. (CVD) Investor Sues Goldman, Sachs & Co. Over Conflict-Tainted Laboratory Corporation of America Holdings (LabCorp) (LH) Advice 12/11/2014 6:13:19 AM
    Covance Inc. (CVD) Reports Third Quarter Net Revenue Growth Of 3.4% To $627 Million, Pro Forma EPS Growth Of 18.2% To $0.98 And Adjusted Net Orders Of $752 Million 11/3/2014 7:41:41 AM
    Laboratory Corporation of America Holdings (LabCorp) (LH) Snatches Up Covance Inc. (CVD) For $6.1 Billion 11/3/2014 6:02:28 AM
    12345678910...